A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Condition:   GHD Interventions:   Drug: GenSci004;   Drug: Genotropin Sponsor:   GeneScience Pharmaceuticals Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials